GlassScriptPhysician profile
Yaohui Chai
NPI 1114140894
$9,554.43
in general payments reported to CMS, 2019-2025
53 companies · $433 in 2025
The $433 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,961 · 2020: $2,027 · 2021: $3,359 · 2022: $36.53 · 2023: $489 · 2024: $248 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.89 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $854.18 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $754.12 | 2019-2025 | |
| Ucb, INC. | $634.86 | 2019-2024 | Rystiggo, Zilbrysq |
| Avanir Pharmaceuticals, INC. | $485.15 | 2019-2021 | |
| Allergan, INC. | $448.68 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $433.22 | 2019-2023 | Ultomiris |
| Sunovion Pharmaceuticals INC. | $422.91 | 2019-2021 | |
| Amgen INC. | $339.01 | 2019-2021 | |
| Abbvie INC. | $338.51 | 2020-2023 | Qulipta, Ubrelvy |
| Acadia Pharmaceuticals INC | $316.50 | 2019-2025 | Nuplazid |
| Biohaven Pharmaceuticals, INC. | $260.62 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $256.49 | 2021 | |
| Csl Behring | $229.99 | 2019-2020 | |
| Biogen, INC. | $229.45 | 2019-2021 | |
| Eisai INC. | $229.13 | 2019-2023 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yaohui Chai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.